Who makes Xeljanz and where is it made?
Xeljanz and Xeljanz XR are made by Pfizer Inc., a pharmaceutical company located in New York, NY. You can contact Pfizer at 1-800-879-3477 or online at Pfizer.com.
If you are looking for information on cost-savings for Xeljanz, you can contact the Xelsource team at 1-844-935-5269, Monday through Friday from 8 AM to 8 PM ET.
When was Xeljanz approved by the FDA?
In November 2012 the U.S. Food and Drug Administration (FDA) first approved Xeljanz (tofacitinib). It is an oral Janus kinase (JAK) inhibitor used for the treatment of:
- rheumatoid arthritis
- psoriatic arthritis
- ulcerative colitis
- ankylosing spondylitis
- polyarticular juvenile idiopathic arthritis.
Xeljanz comes as an oral tablet or an oral solution and is usually given twice a day. Xeljanz XR, an extended-release tablet, is usually given once per day. Follow your doctor's dosing instructions exactly.
If you have kidney or liver problems, take certain medicines, or have certain low blood cell counts, your doctor may need to adjust your dose.
Learn More: Xeljanz Uses, Safety and Side Effects (in detail)
This is not all the information you need to know about Xeljanz (tofacitinib) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Xeljanz information here, and discuss this information and any questions you have with your doctor or other health care provider.
References
- Xeljanz, Xeljanz XR (tofacitinib) prescribing information. Pfizer Inc. Revised 12/2021. Accessed Dec. 15, 2021 at https://labeling.pfizer.com/showlabeling.aspx?id=959#S2.1
- Xeljanz.com. Savings and Support. Accessed Dec. 15, 2021 at https://www.xeljanz.com/
Read next
What are JAK inhibitors and how do they work?
Janus kinase (JAK) inhibitors are a group of medicines that help block immune system signals in the body that can lead to swelling (inflammation) and pain in conditions like rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis. They work by blocking enzymes that lead to overactivity of the immune system. Continue reading
Which JAK inhibitors are approved in the U.S?
List of JAK inhibitors approved in the United States include:
- Cibinqo (abrocitinib)
- Inrebic (fedratinib)
- Jakafi (ruxolitinib)
- Litfulo (ritlecitinib)
- Ojjaara (momelotinib)
- Olumiant (baricitinib)
- Opzelura (ruxolitinib)
- Rinvoq (upadacitinib)
- Vonjo (pacritinib)
- Xeljanz (tofacitinib)
What happens when you stop taking Xeljanz?
Stopping treatment with Xeljanz may cause the symptoms of your condition to return. However, some patients are able to stop Xeljanz without their symptoms flaring up, according to the results of research conducted in patients with rheumatoid arthritis. You should not stop taking Xeljanz without consulting your doctor. Continue reading
Related medical questions
- What are the new drugs for rheumatoid arthritis (RA)?
- How long does Xeljanz take to work?
- Does Xeljanz cause hair loss?
- Can I drink alcohol while taking Xeljanz?
- What is Xeljanz used for and is it a biologic?
- Is Xeljanz an immunosuppressant?
- Does Xeljanz cause weight gain?
- Can you take Xeljanz with antibiotics and antifungals?
- Does Xeljanz cause high blood pressure?
- Is Xeljanz approved for ankylosing spondylitis?
Drug information
Related support groups
- Xeljanz (22 questions, 38 members)
- Tofacitinib (3 questions, 7 members)
- Rheumatoid Arthritis (333 questions, 1,329 members)
- Ulcerative Colitis (73 questions, 187 members)
- Psoriatic Arthritis (89 questions, 281 members)
- Juvenile Idiopathic Arthritis (19 questions, 17 members)